LinkedIn Profile

Access Ambys Medicines historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:ambys 33226533 Sep 17th, 2023 12:00AM Ambys Medicines 5.2K 19.00 Open Biotechnology Research Sep 17th, 2023 05:09AM Sep 17th, 2023 05:09AM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines
private:ambys 33226533 Sep 16th, 2023 12:00AM Ambys Medicines 5.2K 19.00 Open Biotechnology Research Sep 16th, 2023 08:53AM Sep 16th, 2023 03:54PM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines
private:ambys 33226533 Sep 15th, 2023 12:00AM Ambys Medicines 5.2K 19.00 Open Biotechnology Research Sep 15th, 2023 04:54AM Sep 15th, 2023 09:23PM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines
private:ambys 33226533 Sep 14th, 2023 12:00AM Ambys Medicines 5.2K 19.00 Open Biotechnology Research Sep 14th, 2023 06:57AM Sep 14th, 2023 06:57AM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines
private:ambys 33226533 Sep 13th, 2023 12:00AM Ambys Medicines 5.2K 19.00 Open Biotechnology Research Sep 13th, 2023 07:19AM Sep 13th, 2023 07:19AM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines
private:ambys 33226533 Sep 12th, 2023 12:00AM Ambys Medicines 5.2K 19.00 Open Biotechnology Research Sep 12th, 2023 05:35AM Sep 12th, 2023 08:53PM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines
private:ambys 33226533 Sep 11th, 2023 12:00AM Ambys Medicines 5.2K 19.00 Open Biotechnology Research Sep 11th, 2023 07:40AM Sep 11th, 2023 06:37PM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines
private:ambys 33226533 Sep 10th, 2023 12:00AM Ambys Medicines 5.2K 19.00 Open Biotechnology Research Sep 10th, 2023 07:42AM Sep 10th, 2023 07:42AM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines
private:ambys 33226533 Sep 9th, 2023 12:00AM Ambys Medicines 5.2K 20.00 Open Biotechnology Research Sep 9th, 2023 05:10AM Sep 9th, 2023 04:58PM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines
private:ambys 33226533 Sep 8th, 2023 12:00AM Ambys Medicines 5.2K 20.00 Open Biotechnology Research Sep 8th, 2023 05:41AM Sep 8th, 2023 05:41AM Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins. Open Open 131 Oyster Point Blvd South San Francisco California US 94080 Ambys Medicines

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.